FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2612144818> ?p ?o ?g. }

• W2612144818 endingPage "219" @default.
• W2612144818 startingPage "209" @default.
• W2612144818 abstract "Valproic acid, a histone deacetylase inhibitor, has beneficial effects in the setting of cancer, neurologic diseases, and traumatic injuries. In animal models of traumatic injury, a single dose of valproic acid has been shown to reduce mortality. The purpose of this trial was to determine the maximum tolerated single dose of intravenous valproic acid in healthy humans. A double-blinded, placebo-controlled, dose-escalation trial design was used to identify dose-limiting toxicities in healthy subjects who received a single dose of intravenous valproic acid. Patients were monitored for adverse events and data were collected for pharmacokinetic, pharmacodynamic, and safety profiling of valproic acid. Fifty-nine healthy subjects (mean 30 ± 12 years) were enrolled. Forty-four subjects received valproic acid in doses from 15 to 150 mg/kg. The most common adverse events were hypoacusis (n = 19), chills (n = 18), and headache (n = 16). The maximum tolerated dose was 140 mg/kg. Dose-limiting toxicities included headache and nausea lasting longer than 12 h. No drug-related abnormalities were seen in other safety measures including laboratory tests, hemodynamic parameters, cardiac rhythm monitoring, and cognitive testing. A two-compartment model was predictive of valproic acid concentration–time profiles, with a strong correlation (R 2 = 0.56) observed between the number of reported adverse events and the dose level. The maximum tolerated dose of intravenous valproic acid in healthy subjects is 140 mg/kg. This is significantly higher than the previously established maximum tolerated dose of 60–75 mg/kg. Next, the safety and tolerability of high-dose valproic acid will be tested in trauma patients in hemorrhagic shock. ClinicalTrials.gov Identifier: NCT01951560" @default.
• W2612144818 created "2017-05-19" @default.
• W2612144818 creator A5002638591 @default.
• W2612144818 creator A5028241272 @default.
• W2612144818 creator A5031136904 @default.
• W2612144818 creator A5041588125 @default.
• W2612144818 creator A5048443428 @default.
• W2612144818 creator A5058961918 @default.
• W2612144818 creator A5066941695 @default.
• W2612144818 creator A5069778809 @default.
• W2612144818 creator A5072420911 @default.
• W2612144818 creator A5078642980 @default.
• W2612144818 creator A5082500733 @default.
• W2612144818 creator A5089165380 @default.
• W2612144818 date "2017-05-11" @default.
• W2612144818 modified "2023-10-10" @default.
• W2612144818 title "Safety and Tolerability of Intravenous Valproic Acid in Healthy Subjects: A Phase I Dose-Escalation Trial" @default.
• W2612144818 cites W125678881 @default.
• W2612144818 cites W1511815964 @default.
• W2612144818 cites W1847168837 @default.
• W2612144818 cites W1963548334 @default.
• W2612144818 cites W1975013606 @default.
• W2612144818 cites W1996277745 @default.
• W2612144818 cites W2008854521 @default.
• W2612144818 cites W2009826707 @default.
• W2612144818 cites W2020287876 @default.
• W2612144818 cites W2058161128 @default.
• W2612144818 cites W2071888464 @default.
• W2612144818 cites W2088370850 @default.
• W2612144818 cites W2097501252 @default.
• W2612144818 cites W2098036842 @default.
• W2612144818 cites W2099217217 @default.
• W2612144818 cites W2115593774 @default.
• W2612144818 cites W2115769793 @default.
• W2612144818 cites W2133226878 @default.
• W2612144818 cites W2148080316 @default.
• W2612144818 cites W2155043400 @default.
• W2612144818 cites W2157107371 @default.
• W2612144818 cites W2167311298 @default.
• W2612144818 cites W2171185186 @default.
• W2612144818 cites W2314611743 @default.
• W2612144818 cites W2318044872 @default.
• W2612144818 cites W2324514343 @default.
• W2612144818 cites W2413503844 @default.
• W2612144818 cites W2510961465 @default.
• W2612144818 cites W2594367196 @default.
• W2612144818 cites W3021162679 @default.
• W2612144818 cites W36881043 @default.
• W2612144818 doi "https://doi.org/10.1007/s40262-017-0553-1" @default.
• W2612144818 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5699961" @default.
• W2612144818 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28497259" @default.
• W2612144818 hasPublicationYear "2017" @default.
• W2612144818 type Work @default.
• W2612144818 sameAs 2612144818 @default.
• W2612144818 citedByCount "38" @default.
• W2612144818 countsByYear W26121448182017 @default.
• W2612144818 countsByYear W26121448182018 @default.
• W2612144818 countsByYear W26121448182019 @default.
• W2612144818 countsByYear W26121448182020 @default.
• W2612144818 countsByYear W26121448182021 @default.
• W2612144818 countsByYear W26121448182022 @default.
• W2612144818 countsByYear W26121448182023 @default.
• W2612144818 crossrefType "journal-article" @default.
• W2612144818 hasAuthorship W2612144818A5002638591 @default.
• W2612144818 hasAuthorship W2612144818A5028241272 @default.
• W2612144818 hasAuthorship W2612144818A5031136904 @default.
• W2612144818 hasAuthorship W2612144818A5041588125 @default.
• W2612144818 hasAuthorship W2612144818A5048443428 @default.
• W2612144818 hasAuthorship W2612144818A5058961918 @default.
• W2612144818 hasAuthorship W2612144818A5066941695 @default.
• W2612144818 hasAuthorship W2612144818A5069778809 @default.
• W2612144818 hasAuthorship W2612144818A5072420911 @default.
• W2612144818 hasAuthorship W2612144818A5078642980 @default.
• W2612144818 hasAuthorship W2612144818A5082500733 @default.
• W2612144818 hasAuthorship W2612144818A5089165380 @default.
• W2612144818 hasBestOaLocation W26121448182 @default.
• W2612144818 hasConcept C112705442 @default.
• W2612144818 hasConcept C118552586 @default.
• W2612144818 hasConcept C142724271 @default.
• W2612144818 hasConcept C197934379 @default.
• W2612144818 hasConcept C204787440 @default.
• W2612144818 hasConcept C27081682 @default.
• W2612144818 hasConcept C2777172819 @default.
• W2612144818 hasConcept C2778186239 @default.
• W2612144818 hasConcept C2778375690 @default.
• W2612144818 hasConcept C2780580376 @default.
• W2612144818 hasConcept C42219234 @default.
• W2612144818 hasConcept C71924100 @default.
• W2612144818 hasConcept C98274493 @default.
• W2612144818 hasConceptScore W2612144818C112705442 @default.
• W2612144818 hasConceptScore W2612144818C118552586 @default.
• W2612144818 hasConceptScore W2612144818C142724271 @default.
• W2612144818 hasConceptScore W2612144818C197934379 @default.
• W2612144818 hasConceptScore W2612144818C204787440 @default.
• W2612144818 hasConceptScore W2612144818C27081682 @default.
• W2612144818 hasConceptScore W2612144818C2777172819 @default.
• W2612144818 hasConceptScore W2612144818C2778186239 @default.
• W2612144818 hasConceptScore W2612144818C2778375690 @default.

• next